Contact Us
  Search
The Business Research Company Logo
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report 2026
Buy Now
Global Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report 2026

Global Outlook – By Component (Software, Hardware, Services), By Deployment Mode (Cloud-Based, On-Premises), By Application (Remote Patient Monitoring, Personalized Care Management, Medication Adherence, Patient Education, Other Applications), By End-User (Hospitals And Clinics, Homecare Settings, Research And Academic Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Overview

• Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach market size has reached to $1.93 billion in 2025 • Expected to grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 28% • Growth Driver: Rising Burden Of Cardiovascular Diseases Fueling The Growth Of The Market Amid Increasing Unhealthy Dietary Habits • Market Trend: Leveraging Artificial Intelligence (AI)-Driven Non-Invasive Digital Platforms For At-Home Heart Failure Management • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?

An artificial intelligence (AI)-powered chronic heart failure digital coach is a technology solution that delivers real-time guidance and personalized insights to support the management of chronic heart failure. It continuously analyzes patient data to optimize health outcomes and promote proactive care. The system enhances decision-making, improves adherence to care plans, and enables timely intervention. Its intelligent feedback loop drives more effective monitoring and self-management of heart health. The main components of artificial intelligence (AI)-powered chronic heart failure digital coaches are software, hardware, and services. Software refers to AI-driven applications that analyze patient data, provide personalized recommendations, and facilitate remote monitoring and care management. The deployment modes are cloud-based and on-premises and are used for various applications such as remote patient monitoring, personalized care management, medication adherence, patient education, and others, and the key end-users are hospitals and clinics, home care settings, research and academic institutes, and others.
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Global Report 2026 Market Report bar graph

What Is The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Size and Share 2026?

The artificial intelligence (ai)-powered chronic heart failure digital coach market size has grown exponentially in recent years. It will grow from $1.93 billion in 2025 to $2.48 billion in 2026 at a compound annual growth rate (CAGR) of 28.3%. The growth in the historic period can be attributed to increasing incidence of heart failure, expansion of remote patient monitoring adoption, rising healthcare digitization, growing availability of connected medical devices, increasing focus on preventive cardiac care.

What Is The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Growth Forecast?

The artificial intelligence (ai)-powered chronic heart failure digital coach market size is expected to see exponential growth in the next few years. It will grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to advancements in ai-powered clinical analytics, growing adoption of personalized care management, expansion of home-based cardiac monitoring, rising investments in digital cardiology platforms, increasing demand for continuous patient engagement solutions. Major trends in the forecast period include increasing deployment of AI-based cardiac monitoring coaches, growing integration with wearable heart sensors, rising use of predictive health analytics, expansion of remote chronic care platforms, enhanced focus on patient self-management tools.

Global Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Segmentation

1) By Component: Software, Hardware, Services 2) By Deployment Mode: Cloud-Based, On-Premises 3) By Application: Remote Patient Monitoring, Personalized Care Management, Medication Adherence, Patient Education, Other Applications 4) By End-User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes, Other End-Users Subsegments: 1) By Software: Cloud-Based Platforms, Mobile Applications, Data Analytics Tools, Patient Monitoring Dashboards, Integration Middleware 2) By Hardware: Wearable Devices, Smart Sensors, Connected Medical Devices, Home Monitoring Equipment, Edge Computing Devices 3) By Services: Implementation And Integration Services, Consulting Services, Maintenance And Support Services, Training And Education Services, Remote Patient Monitoring Services

What Is The Driver Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?

The rising burden of cardiovascular diseases is expected to propel the growth of the artificial intelligence (AI)-powered chronic heart failure digital coach market going forward. Cardiovascular diseases refer to a group of disorders of the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and other conditions affecting the circulatory system. The prevalence of cardiovascular diseases is increasing as diets high in processed foods and salt raise blood pressure and cholesterol, elevating heart disease risk. An AI-powered chronic heart failure digital coach aids cardiovascular disease management by monitoring health in real time and offering personalized guidance on medications and lifestyle while enabling early complication detection and proactive care. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, 919,032 people in the United States died from cardiovascular disease in 2023, accounting for approximately one in every three deaths nationwide. Therefore, the rising burden of cardiovascular diseases is driving the growth of the artificial intelligence (AI)-powered chronic heart failure digital coach industry.

Key Players In The Global Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market

Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?

In September 2025, Innovaccer, a US-based digital healthcare company, acquired Story Health for an undisclosed amount. With this acquisition, Innovaccer gains access to Story Health’s virtual care platform, remote patient monitoring infrastructure, and care-team engagement expertise, thereby enhancing its personalized digital care capabilities while improving its operational scale and service reach. Story Health is a US-based digital health company that leverages artificial intelligence (AI) to transform the management of chronic heart failure (CHF) through its AI-powered platform.

Regional Outlook

North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?

The artificial intelligence (AI)-powered chronic heart failure digital coach market consists of revenues earned by entities by providing services such as data management services, clinical workflow optimization services, predictive analytics services, and patient engagement services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered chronic heart failure digital coach market also includes sales of digital health assistants, home monitoring equipment, smart sensors, and artificial intelligence (AI)-driven treatment recommendation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report 2026?

The artificial intelligence (ai)-powered chronic heart failure digital coach market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-powered chronic heart failure digital coach industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$2.48 billion
Revenue Forecast In 2035$6.64 billion
Growth RateCAGR of 28.3% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredComponent, Deployment Mode, Application, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledKoninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach market was valued at $1.93 billion in 2025, increased to $2.48 billion in 2026, and is projected to reach $6.64 billion by 2030.
The global Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach market is expected to grow at a CAGR of 28.0% from 2026 to 2035 to reach $6.64 billion by 2035.
Some Key Players in the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach market Include, Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS. .
Major trend in this market includes: Leveraging Artificial Intelligence (AI)-Driven Non-Invasive Digital Platforms For At-Home Heart Failure Management. For further insights on this market.
Request for Sample
North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2025. The regions covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us